Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceutical companies ranked by total liabilities, at SEK 1.39T, ahead of Pfizer (SEK 1.23T) and Johnson & Johnson (SEK 1.19T). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieSEK 1.39T
- Median
- SEK 21.2B
- Combined market value
- SEK 51.72T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | SEK 1.39T | SEK 5.16T | SEK 2,920.71 | 1.78% down | 26% up | ||
| 2 | PfizerPFE · Health Care | SEK 1.23T | SEK 1.63T | SEK 286.33 | 0.97% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | SEK 1.19T | SEK 6.73T | SEK 2,797.22 | 1.17% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | SEK 872.8B | SEK 12.63T | SEK 14,175.21 | 1.39% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | SEK 855.1B | SEK 3.47T | SEK 1,406.45 | 3.40% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | SEK 726.5B | SEK 1.25T | SEK 611.46 | 1.86% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | SEK 663.7B | SEK 2.83T | SEK 1,825.04 | 1.40% down | 2% up | ||
| 8 | NovartisNVS · Health Care | SEK 654B | SEK 2.99T | SEK 1,584.66 | 1.94% down | 25% up | ||
| 9 | SanofiSNY · Health Care | SEK 620.8B | SEK 1.15T | SEK 480.82 | 0.39% down | 4% down | ||
| 10 | GSKGSK · Health Care | SEK 608.8B | SEK 993.8B | SEK 495.79 | 0.85% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | SEK 525.7B | SEK 1.77T | SEK 402.61 | 2.59% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | SEK 514B | SEK 694.2B | SEK 217.28 | 1.13% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | SEK 344.7B | SEK 1.84T | SEK 1,061.35 | 0.19% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | SEK 333.4B | SEK 499.6B | SEK 428.21 | 1.07% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | SEK 228.3B | SEK 240.6B | SEK 209.86 | 1.05% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | SEK 136.4B | SEK 58.5B | SEK 85.97 | 1.91% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | SEK 123.2B | SEK 351.3B | SEK 864.69 | 1.99% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | SEK 100.6B | SEK 405.4B | SEK 704.99 | 1.08% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | SEK 94.5B | SEK 996.1B | SEK 9,628.60 | 1.01% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | SEK 74.5B | SEK 161.1B | SEK 2,509.26 | 2.65% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | SEK 71.4B | SEK 322.6B | SEK 523.16 | 0.86% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | SEK 70.9B | SEK 1.39T | SEK 5,473.95 | 0.90% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | SEK 69.2B | SEK 136.8B | SEK 273.69 | 4.26% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | SEK 42.4B | SEK 205.4B | SEK 1,533.22 | 3.53% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | SEK 38.9B | SEK 470.1B | SEK 4,115.71 | 1.93% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | SEK 37.3B | SEK 78.2B | SEK 224.39 | 4.62% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | SEK 31.5B | SEK 51.2B | SEK 613.19 | 0.03% up | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | SEK 30.8B | SEK 47.1B | SEK 282.88 | 3.32% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | SEK 30.6B | SEK 154.6B | SEK 793.85 | 1.78% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | SEK 21.5B | SEK 127.4B | SEK 152.83 | 1.75% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | SEK 21.2B | SEK 73.1B | SEK 524.58 | 0.01% up | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | SEK 16.5B | SEK 181.1B | SEK 2,760.97 | 0.25% up | 28% up | ||
| 33 | InsmedINSM · Health Care | SEK 15.5B | SEK 268.9B | SEK 1,225.66 | 0.96% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | SEK 15.3B | SEK 119.2B | SEK 615.17 | 3.53% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | SEK 9B | SEK 62.4B | SEK 441.56 | 1.14% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | SEK 8B | SEK 252.1B | SEK 5,919.93 | 0.20% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | SEK 7.4B | SEK 32B | SEK 164.92 | 0.81% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | SEK 6.8B | SEK 80.2B | SEK 477.10 | 3.37% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | SEK 6.7B | SEK 96.3B | SEK 4,144.70 | 3.29% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | SEK 6.1B | SEK 71.9B | SEK 1,367.33 | 0.96% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | SEK 5.5B | SEK 61.1B | SEK 3,055.02 | 2.39% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | SEK 5.4B | SEK 61.3B | SEK 938.62 | 0.52% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | SEK 5B | SEK 49.9B | SEK 519.96 | 0.20% up | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | SEK 4.2B | SEK 283.7B | SEK 391.59 | 0.39% down | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | SEK 4.2B | SEK 101.4B | SEK 671.12 | 5.38% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | SEK 3.1B | SEK 49.8B | SEK 286.49 | 1.29% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | SEK 2.1B | SEK 84.5B | SEK 1,219.27 | 2.96% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SEK 2B | SEK 76.1B | SEK 968.12 | 0.23% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | SEK 1.9B | SEK 75.9B | SEK 693.52 | 2.54% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | SEK 1.5B | SEK 74.7B | SEK 853.06 | 2.31% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | SEK 1.1B | SEK 40.2B | SEK 293.85 | 1.51% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | SEK 937.6M | SEK 85.6B | SEK 106.99 | 1.27% down | 36% down | ||
| 53 | ErascaERAS · Health Care | SEK 720.9M | SEK 48.2B | SEK 137.30 | 2.66% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | SEK 635.2M | SEK 93.5B | SEK 984.17 | 3.30% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | SEK 607M | SEK 87.7B | SEK 3,136.52 | 1.24% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | SEK 543.1M | SEK 83.6B | SEK 1,280.20 | 1.11% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | SEK 381M | SEK 50B | SEK 887.79 | 0.51% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | SEK 308.2M | SEK 46.5B | SEK 424.40 | 0.59% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | SEK 169.5M | SEK 66.3B | SEK 977.06 | 0.11% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | SEK 102.3M | SEK 65B | SEK 1,600.81 | 0.06% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | SEK 93M | SEK 53.4B | SEK 1,266.18 | 0.76% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1555 SEK).
Questions and answers
Which pharmaceutical companies rank first by total liabilities?
AbbVie (SEK 1.39T), Pfizer (SEK 1.23T) and Johnson & Johnson (SEK 1.19T) are the top three of the 61 pharmaceutical companies ranked by total liabilities as of 18 Nov 2026, 18:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of SEK 51.72T as of 18 Nov 2026, 18:41 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.